| J0120 |
Injection, tetracycline, up to 250 mg |
| J0121 |
Injection, omadacycline, 1 mg |
| J0122 |
Injection, eravacycline, 1 mg |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0130 |
Injection abciximab, 10 mg |
| J0131 |
Injection, acetaminophen, 10 mg |
| J0132 |
Injection, acetylcysteine, 100 mg |
| J0133 |
Injection, acyclovir, 5 mg |
| J0135 |
Injection, adalimumab, 20 mg |
| J0150 |
Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) |
| J0151 |
Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
| J0178 |
Injection, aflibercept, 1 mg |
| J0179 |
Injection, brolucizumab-dbll, 1 mg |
| J0180 |
Injection, agalsidase beta, 1 mg |
| J0185 |
Injection, aprepitant, 1 mg |
| J0190 |
Injection, biperiden lactate, per 5 mg |
| J0200 |
Injection, alatrofloxacin mesylate, 100 mg |
| J0202 |
Injection, alemtuzumab, 1 mg |
| J0205 |
Injection, alglucerase, per 10 units |
| J0207 |
Injection, amifostine, 500 mg |
| J0210 |
Injection, methyldopate hcl, up to 250 mg |
| J0215 |
Injection, alefacept, 0.5 mg |
| J0220 |
Injection, alglucosidase alfa, 10 mg, not otherwise specified |
| J0221 |
Injection, alglucosidase alfa, (lumizyme), 10 mg |
| J0222 |
Injection, patisiran, 0.1 mg |
| J0223 |
Injection, givosiran, 0.5 mg |
| J0256 |
Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg |
| J0257 |
Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg |
| J0270 |
Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0275 |
Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0278 |
Injection, amikacin sulfate, 100 mg |
| J0280 |
Injection, aminophyllin, up to 250 mg |
| J0282 |
Injection, amiodarone hydrochloride, 30 mg |
| J0285 |
Injection, amphotericin b, 50 mg |
| J0287 |
Injection, amphotericin b lipid complex, 10 mg |
| J0288 |
Injection, amphotericin b cholesteryl sulfate complex, 10 mg |
| J0289 |
Injection, amphotericin b liposome, 10 mg |
| J0290 |
Injection, ampicillin sodium, 500 mg |
| J0291 |
Injection, plazomicin, 5 mg |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
| J0300 |
Injection, amobarbital, up to 125 mg |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
| J0348 |
Injection, anidulafungin, 1 mg |
| J0350 |
Injection, anistreplase, per 30 units |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
| J0364 |
Injection, apomorphine hydrochloride, 1 mg |
| J0365 |
Injection, aprotonin, 10,000 kiu |
| J0380 |
Injection, metaraminol bitartrate, per 10 mg |
| J0390 |
Injection, chloroquine hydrochloride, up to 250 mg |
| J0395 |
Injection, arbutamine hcl, 1 mg |
| J0400 |
Injection, aripiprazole, intramuscular, 0.25 mg |
| J0401 |
Injection, aripiprazole, extended release, 1 mg |
| J0456 |
Injection, azithromycin, 500 mg |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
| J0470 |
Injection, dimercaprol, per 100 mg |
| J0475 |
Injection, baclofen, 10 mg |
| J0476 |
Injection, baclofen, 50 mcg for intrathecal trial |
| J0480 |
Injection, basiliximab, 20 mg |
| J0485 |
Injection, belatacept, 1 mg |
| J0490 |
Injection, belimumab, 10 mg |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
| J0515 |
Injection, benztropine mesylate, per 1 mg |
| J0517 |
Injection, benralizumab, 1 mg |
| J0520 |
Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg |
| J0558 |
Injection, penicillin g benzathine and penicillin g procaine, 100,000 units |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
| J0565 |
Injection, bezlotoxumab, 10 mg |
| J0567 |
Injection, cerliponase alfa, 1 mg |
| J0570 |
Buprenorphine implant, 74.2 mg |
| J0571 |
Buprenorphine, oral, 1 mg |
| J0572 |
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
| J0573 |
Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
| J0575 |
Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine |
| J0583 |
Injection, bivalirudin, 1 mg |
| J0584 |
Injection, burosumab-twza 1 mg |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
| J0586 |
Injection, abobotulinumtoxina, 5 units |
| J0587 |
Injection, rimabotulinumtoxinb, 100 units |
| J0588 |
Injection, incobotulinumtoxin a, 1 unit |
| J0591 |
Injection, deoxycholic acid, 1 mg |
| J0592 |
Injection, buprenorphine hydrochloride, 0.1 mg |
| J0593 |
Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) |
| J0594 |
injection, busulfan, 1 mg |
| J0595 |
Injection, butorphanol tartrate, 1 mg |
| J0596 |
Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units |
| J0597 |
Injection, c-1 esterase inhibitor (human), berinert, 10 units |
| J0598 |
Injection, c-1 esterase inhibitor (human), cinryze, 10 units |
| J0599 |
Injection, c-1 esterase inhibitor (human), (haegarda), 10 units |
| J0600 |
Injection, edetate calcium disodium, up to 1000 mg |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
| J0610 |
Injection, calcium gluconate, per 10 ml |
| J0620 |
Injection, calcium glycerophosphate and calcium lactate, per 10 ml |
| J0630 |
Injection, calcitonin salmon, up to 400 units |
| J0636 |
Injection, calcitriol, 0.1 mcg |
| J0637 |
Injection, caspofungin acetate, 5 mg |
| J0638 |
Injection, canakinumab, 1 mg |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
| J0641 |
Injection, levoleucovorin, not otherwise specified, 0.5 mg |
| J0642 |
Injection, levoleucovorin (khapzory), 0.5 mg |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
| J0690 |
Injection, cefazolin sodium, 500 mg |
| J0691 |
Injection, lefamulin, 1 mg |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
| J0693 |
Injection, cefiderocol, 5 mg |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
| J0695 |
Injection, ceftolozane 50 mg and tazobactam 25 mg |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
| J0697 |
Injection, sterile cefuroxime sodium, per 750 mg |
| J0698 |
Injection, cefotaxime sodium, per gm |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
| J0706 |
Injection, caffeine citrate, 5 mg |
| J0710 |
Injection, cephapirin sodium, up to 1 gm |
| J0712 |
Injection, ceftaroline fosamil, 10 mg |
| J0713 |
Injection, ceftazidime, per 500 mg |
| J0714 |
Injection, ceftazidime and avibactam, 0.5 g/0.125 g |
| J0715 |
Injection, ceftizoxime sodium, per 500 mg |
| J0716 |
Injection, centruroides immune f(ab)2, up to 120 milligrams |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J0720 |
Injection, chloramphenicol sodium succinate, up to 1 gm |
| J0725 |
Injection, chorionic gonadotropin, per 1,000 usp units |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
| J0740 |
Injection, cidofovir, 375 mg |
| J0742 |
Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg |
| J0743 |
Injection, cilastatin sodium; imipenem, per 250 mg |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
| J0745 |
Injection, codeine phosphate, per 30 mg |
| J0760 |
Injection, colchicine, per 1 mg |
| J0770 |
Injection, colistimethate sodium, up to 150 mg |
| J0775 |
Injection, collagenase, clostridium histolyticum, 0.01 mg |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
| J0791 |
Injection, crizanlizumab-tmca, 5 mg |
| J0795 |
Injection, corticorelin ovine triflutate, 1 microgram |
| J0800 |
Injection, corticotropin, up to 40 units |
| J0833 |
Injection, cosyntropin, not otherwise specified, 0.25 mg |
| J0834 |
Injection, cosyntropin, 0.25 mg |
| J0840 |
Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram |
| J0841 |
Injection, crotalidae immune f(ab')2 (equine), 120 mg |
| J0850 |
Injection, cytomegalovirus immune globulin intravenous (human), per vial |
| J0875 |
Injection, dalbavancin, 5 mg |
| J0878 |
Injection, daptomycin, 1 mg |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
| J0883 |
Injection, argatroban, 1 mg (for non-esrd use) |
| J0884 |
Injection, argatroban, 1 mg (for esrd on dialysis) |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
| J0886 |
Injection, epoetin alfa, 1000 units (for esrd on dialysis) |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
| J0888 |
Injection, epoetin beta, 1 microgram, (for non esrd use) |
| J0890 |
Injection, peginesatide, 0.1 mg (for esrd on dialysis) |
| J0894 |
Injection, decitabine, 1 mg |
| J0895 |
Injection, deferoxamine mesylate, 500 mg |
| J0896 |
Injection, luspatercept-aamt, 0.25 mg |
| J0897 |
Injection, denosumab, 1 mg |
| J0900 |
Injection, testosterone enanthate and estradiol valerate, up to 1 cc |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
| J1000 |
Injection, depo-estradiol cypionate, up to 5 mg |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
| J1060 |
Injection, testosterone cypionate and estradiol cypionate, up to 1 ml |
| J1070 |
Injection, testosterone cypionate, up to 100 mg |
| J1071 |
Injection, testosterone cypionate, 1 mg |
| J1080 |
Injection, testosterone cypionate, 1 cc, 200 mg |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
| J1095 |
Injection, dexamethasone 9 percent, intraocular, 1 microgram |
| J1096 |
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
| J1110 |
Injection, dihydroergotamine mesylate, per 1 mg |
| J1120 |
Injection, acetazolamide sodium, up to 500 mg |
| J1130 |
Injection, diclofenac sodium, 0.5 mg |
| J1160 |
Injection, digoxin, up to 0.5 mg |
| J1162 |
Injection, digoxin immune fab (ovine), per vial |
| J1165 |
Injection, phenytoin sodium, per 50 mg |
| J1170 |
Injection, hydromorphone, up to 4 mg |
| J1180 |
Injection, dyphylline, up to 500 mg |
| J1190 |
Injection, dexrazoxane hydrochloride, per 250 mg |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
| J1201 |
Injection, cetirizine hydrochloride, 0.5 mg |
| J1205 |
Injection, chlorothiazide sodium, per 500 mg |
| J1212 |
Injection, dmso, dimethyl sulfoxide, 50%, 50 ml |
| J1230 |
Injection, methadone hcl, up to 10 mg |
| J1240 |
Injection, dimenhydrinate, up to 50 mg |
| J1245 |
Injection, dipyridamole, per 10 mg |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
| J1260 |
Injection, dolasetron mesylate, 10 mg |
| J1265 |
Injection, dopamine hcl, 40 mg |
| J1267 |
Injection, doripenem, 10 mg |
| J1270 |
Injection, doxercalciferol, 1 mcg |
| J1290 |
Injection, ecallantide, 1 mg |
| J1300 |
Injection, eculizumab, 10 mg |
| J1301 |
Injection, edaravone, 1 mg |
| J1303 |
Injection, ravulizumab-cwvz, 10 mg |
| J1320 |
Injection, amitriptyline hcl, up to 20 mg |
| J1322 |
Injection, elosulfase alfa, 1 mg |
| J1324 |
Injection, enfuvirtide, 1 mg |
| J1325 |
Injection, epoprostenol, 0.5 mg |
| J1327 |
Injection, eptifibatide, 5 mg |
| J1330 |
Injection, ergonovine maleate, up to 0.2 mg |
| J1335 |
Injection, ertapenem sodium, 500 mg |
| J1364 |
Injection, erythromycin lactobionate, per 500 mg |
| J1380 |
Injection, estradiol valerate, up to 10 mg |
| J1410 |
Injection, estrogen conjugated, per 25 mg |
| J1428 |
Injection, eteplirsen, 10 mg |
| J1429 |
Injection, golodirsen, 10 mg |
| J1430 |
Injection, ethanolamine oleate, 100 mg |
| J1435 |
Injection, estrone, per 1 mg |
| J1436 |
Injection, etidronate disodium, per 300 mg |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
| J1438 |
Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
| J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram |
| J1443 |
Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron |
| J1444 |
Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron |
| J1446 |
Injection, tbo-filgrastim, 5 micrograms |
| J1447 |
Injection, tbo-filgrastim, 1 microgram |
| J1450 |
Injection fluconazole, 200 mg |
| J1451 |
Injection, fomepizole, 15 mg |
| J1452 |
Injection, fomivirsen sodium, intraocular, 1.65 mg |
| J1453 |
Injection, fosaprepitant, 1 mg |
| J1454 |
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg |
| J1455 |
Injection, foscarnet sodium, per 1000 mg |
| J1457 |
Injection, gallium nitrate, 1 mg |
| J1458 |
Injection, galsulfase, 1 mg |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
| J1460 |
Injection, gamma globulin, intramuscular, 1 cc |
| J1555 |
Injection, immune globulin (cuvitru), 100 mg |
| J1556 |
Injection, immune globulin (bivigam), 500 mg |
| J1557 |
Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg |
| J1558 |
Injection, immune globulin (xembify), 100 mg |
| J1559 |
Injection, immune globulin (hizentra), 100 mg |
| J1560 |
Injection, gamma globulin, intramuscular, over 10 cc |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
| J1562 |
Injection, immune globulin (vivaglobin), 100 mg |
| J1566 |
Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg |
| J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
| J1570 |
Injection, ganciclovir sodium, 500 mg |
| J1571 |
Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml |
| J1572 |
Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg |
| J1573 |
Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml |
| J1575 |
Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
| J1590 |
Injection, gatifloxacin, 10 mg |
| J1595 |
Injection, glatiramer acetate, 20 mg |
| J1599 |
Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg |
| J1600 |
Injection, gold sodium thiomalate, up to 50 mg |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
| J1620 |
Injection, gonadorelin hydrochloride, per 100 mcg |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
| J1627 |
Injection, granisetron, extended-release, 0.1 mg |
| J1628 |
Injection, guselkumab, 1 mg |
| J1630 |
Injection, haloperidol, up to 5 mg |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
| J1632 |
Injection, brexanolone, 1 mg |
| J1640 |
Injection, hemin, 1 mg |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
| J1644 |
Injection, heparin sodium, per 1000 units |
| J1645 |
Injection, dalteparin sodium, per 2500 iu |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
| J1652 |
Injection, fondaparinux sodium, 0.5 mg |
| J1655 |
Injection, tinzaparin sodium, 1000 iu |
| J1670 |
Injection, tetanus immune globulin, human, up to 250 units |
| J1675 |
Injection, histrelin acetate, 10 micrograms |
| J1700 |
Injection, hydrocortisone acetate, up to 25 mg |
| J1710 |
Injection, hydrocortisone sodium phosphate, up to 50 mg |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
| J1725 |
Injection, hydroxyprogesterone caproate, 1 mg |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
| J1729 |
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg |
| J1730 |
Injection, diazoxide, up to 300 mg |
| J1738 |
Injection, meloxicam, 1 mg |
| J1740 |
Injection, ibandronate sodium, 1 mg |
| J1741 |
Injection, ibuprofen, 100 mg |
| J1742 |
Injection, ibutilide fumarate, 1 mg |
| J1743 |
Injection, idursulfase, 1 mg |
| J1744 |
Injection, icatibant, 1 mg |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
| J1746 |
Injection, ibalizumab-uiyk, 10 mg |
| J1750 |
Injection, iron dextran, 50 mg |
| J1756 |
Injection, iron sucrose, 1 mg |
| J1786 |
Injection, imiglucerase, 10 units |
| J1790 |
Injection, droperidol, up to 5 mg |
| J1800 |
Injection, propranolol hcl, up to 1 mg |
| J1810 |
Injection, droperidol and fentanyl citrate, up to 2 ml ampule |
| J1815 |
Injection, insulin, per 5 units |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
| J1823 |
Injection, inebilizumab-cdon, 1 mg |
| J1826 |
Injection, interferon beta-1a, 30 mcg |
| J1830 |
Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J1833 |
Injection, isavuconazonium, 1 mg |
| J1835 |
Injection, itraconazole, 50 mg |
| J1840 |
Injection, kanamycin sulfate, up to 500 mg |
| J1850 |
Injection, kanamycin sulfate, up to 75 mg |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
| J1890 |
Injection, cephalothin sodium, up to 1 gram |
| J1930 |
Injection, lanreotide, 1 mg |
| J1931 |
Injection, laronidase, 0.1 mg |
| J1940 |
Injection, furosemide, up to 20 mg |
| J1942 |
Injection, aripiprazole lauroxil, 1 mg |
| J1943 |
Injection, aripiprazole lauroxil, (aristada initio), 1 mg |
| J1944 |
Injection, aripiprazole lauroxil, (aristada), 1 mg |
| J1945 |
Injection, lepirudin, 50 mg |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
| J1953 |
Injection, levetiracetam, 10 mg |
| J1955 |
Injection, levocarnitine, per 1 gm |
| J1956 |
Injection, levofloxacin, 250 mg |
| J1960 |
Injection, levorphanol tartrate, up to 2 mg |
| J1980 |
Injection, hyoscyamine sulfate, up to 0.25 mg |
| J1990 |
Injection, chlordiazepoxide hcl, up to 100 mg |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
| J2020 |
Injection, linezolid, 200 mg |
| J2060 |
Injection, lorazepam, 2 mg |
| J2062 |
Loxapine for inhalation, 1 mg |
| J2150 |
Injection, mannitol, 25% in 50 ml |
| J2170 |
Injection, mecasermin, 1 mg |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
| J2180 |
Injection, meperidine and promethazine hcl, up to 50 mg |
| J2182 |
Injection, mepolizumab, 1 mg |
| J2185 |
Injection, meropenem, 100 mg |
| J2186 |
Injection, meropenem and vaborbactam, 10mg/10mg (20mg) |
| J2210 |
Injection, methylergonovine maleate, up to 0.2 mg |
| J2212 |
Injection, methylnaltrexone, 0.1 mg |
| J2248 |
Injection, micafungin sodium, 1 mg |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
| J2260 |
Injection, milrinone lactate, 5 mg |
| J2265 |
Injection, minocycline hydrochloride, 1 mg |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
| J2271 |
Injection, morphine sulfate, 100mg |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
| J2275 |
Injection, morphine sulfate (preservative-free sterile solution), per 10 mg |
| J2278 |
Injection, ziconotide, 1 microgram |
| J2280 |
Injection, moxifloxacin, 100 mg |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
| J2320 |
Injection, nandrolone decanoate, up to 50 mg |
| J2323 |
Injection, natalizumab, 1 mg |
| J2325 |
Injection, nesiritide, 0.1 mg |
| J2326 |
Injection, nusinersen, 0.1 mg |
| J2350 |
Injection, ocrelizumab, 1 mg |
| J2353 |
Injection, octreotide, depot form for intramuscular injection, 1 mg |
| J2354 |
Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg |
| J2355 |
Injection, oprelvekin, 5 mg |
| J2357 |
Injection, omalizumab, 5 mg |
| J2358 |
Injection, olanzapine, long-acting, 1 mg |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
| J2400 |
Injection, chloroprocaine hydrochloride, per 30 ml |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
| J2407 |
Injection, oritavancin, 10 mg |
| J2410 |
Injection, oxymorphone hcl, up to 1 mg |
| J2425 |
Injection, palifermin, 50 micrograms |
| J2426 |
Injection, paliperidone palmitate extended release, 1 mg |
| J2430 |
Injection, pamidronate disodium, per 30 mg |
| J2440 |
Injection, papaverine hcl, up to 60 mg |
| J2460 |
Injection, oxytetracycline hcl, up to 50 mg |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
| J2501 |
Injection, paricalcitol, 1 mcg |
| J2502 |
Injection, pasireotide long acting, 1 mg |
| J2503 |
Injection, pegaptanib sodium, 0.3 mg |
| J2504 |
Injection, pegademase bovine, 25 iu |
| J2505 |
Injection, pegfilgrastim, 6 mg |
| J2507 |
Injection, pegloticase, 1 mg |
| J2510 |
Injection, penicillin g procaine, aqueous, up to 600,000 units |
| J2513 |
Injection, pentastarch, 10% solution, 100 ml |
| J2515 |
Injection, pentobarbital sodium, per 50 mg |
| J2540 |
Injection, penicillin g potassium, up to 600,000 units |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
| J2545 |
Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg |
| J2547 |
Injection, peramivir, 1 mg |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
| J2562 |
Injection, plerixafor, 1 mg |
| J2590 |
Injection, oxytocin, up to 10 units |
| J2597 |
Injection, desmopressin acetate, per 1 mcg |
| J2650 |
Injection, prednisolone acetate, up to 1 ml |
| J2670 |
Injection, tolazoline hcl, up to 25 mg |
| J2675 |
Injection, progesterone, per 50 mg |
| J2680 |
Injection, fluphenazine decanoate, up to 25 mg |
| J2690 |
Injection, procainamide hcl, up to 1 gm |
| J2700 |
Injection, oxacillin sodium, up to 250 mg |
| J2704 |
Injection, propofol, 10 mg |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
| J2720 |
Injection, protamine sulfate, per 10 mg |
| J2724 |
Injection, protein c concentrate, intravenous, human, 10 iu |
| J2725 |
Injection, protirelin, per 250 mcg |
| J2730 |
Injection, pralidoxime chloride, up to 1 gm |
| J2760 |
Injection, phentolamine mesylate, up to 5 mg |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
| J2770 |
Injection, quinupristin/dalfopristin, 500 mg (150/350) |
| J2778 |
Injection, ranibizumab, 0.1 mg |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
| J2783 |
Injection, rasburicase, 0.5 mg |
| J2785 |
Injection, regadenoson, 0.1 mg |
| J2786 |
Injection, reslizumab, 1 mg |
| J2787 |
Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml |
| J2788 |
Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
| J2792 |
Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu |
| J2793 |
Injection, rilonacept, 1 mg |
| J2794 |
Injection, risperidone (risperdal consta), 0.5 mg |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
| J2796 |
Injection, romiplostim, 10 micrograms |
| J2797 |
Injection, rolapitant, 0.5 mg |
| J2798 |
Injection, risperidone, (perseris), 0.5 mg |
| J2800 |
Injection, methocarbamol, up to 10 ml |
| J2805 |
Injection, sincalide, 5 micrograms |
| J2810 |
Injection, theophylline, per 40 mg |
| J2820 |
Injection, sargramostim (gm-csf), 50 mcg |
| J2840 |
Injection, sebelipase alfa, 1 mg |
| J2850 |
Injection, secretin, synthetic, human, 1 microgram |
| J2860 |
Injection, siltuximab, 10 mg |
| J2910 |
Injection, aurothioglucose, up to 50 mg |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
| J2940 |
Injection, somatrem, 1 mg |
| J2941 |
Injection, somatropin, 1 mg |
| J2950 |
Injection, promazine hcl, up to 25 mg |
| J2993 |
Injection, reteplase, 18.1 mg |
| J2995 |
Injection, streptokinase, per 250,000 iu |
| J2997 |
Injection, alteplase recombinant, 1 mg |
| J3000 |
Injection, streptomycin, up to 1 gm |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
| J3030 |
Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J3031 |
Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
| J3032 |
Injection, eptinezumab-jjmr, 1 mg |
| J3060 |
Injection, taliglucerase alfa, 10 units |
| J3070 |
Injection, pentazocine, 30 mg |
| J3090 |
Injection, tedizolid phosphate, 1 mg |
| J3095 |
Injection, telavancin, 10 mg |
| J3101 |
Injection, tenecteplase, 1 mg |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
| J3110 |
Injection, teriparatide, 10 mcg |
| J3111 |
Injection, romosozumab-aqqg, 1 mg |
| J3120 |
Injection, testosterone enanthate, up to 100 mg |
| J3121 |
Injection, testosterone enanthate, 1 mg |
| J3130 |
Injection, testosterone enanthate, up to 200 mg |
| J3140 |
Injection, testosterone suspension, up to 50 mg |
| J3145 |
Injection, testosterone undecanoate, 1 mg |
| J3150 |
Injection, testosterone propionate, up to 100 mg |
| J3230 |
Injection, chlorpromazine hcl, up to 50 mg |
| J3240 |
Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial |
| J3241 |
Injection, teprotumumab-trbw, 10 mg |
| J3243 |
Injection, tigecycline, 1 mg |
| J3245 |
Injection, tildrakizumab, 1 mg |
| J3246 |
Injection, tirofiban hcl, 0.25 mg |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
| J3262 |
Injection, tocilizumab, 1 mg |
| J3265 |
Injection, torsemide, 10 mg/ml |
| J3280 |
Injection, thiethylperazine maleate, up to 10 mg |
| J3285 |
Injection, treprostinil, 1 mg |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
| J3302 |
Injection, triamcinolone diacetate, per 5 mg |
| J3303 |
Injection, triamcinolone hexacetonide, per 5 mg |
| J3304 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
| J3305 |
Injection, trimetrexate glucuronate, per 25 mg |
| J3310 |
Injection, perphenazine, up to 5 mg |
| J3315 |
Injection, triptorelin pamoate, 3.75 mg |
| J3316 |
Injection, triptorelin, extended-release, 3.75 mg |
| J3320 |
Injection, spectinomycin dihydrochloride, up to 2 gm |
| J3350 |
Injection, urea, up to 40 gm |
| J3355 |
Injection, urofollitropin, 75 iu |
| J3357 |
Ustekinumab, for subcutaneous injection, 1 mg |
| J3358 |
Ustekinumab, for intravenous injection, 1 mg |
| J3360 |
Injection, diazepam, up to 5 mg |
| J3364 |
Injection, urokinase, 5000 iu vial |
| J3365 |
Injection, iv, urokinase, 250,000 i.u. vial |
| J3370 |
Injection, vancomycin hcl, 500 mg |
| J3380 |
Injection, vedolizumab, 1 mg |
| J3385 |
Injection, velaglucerase alfa, 100 units |
| J3396 |
Injection, verteporfin, 0.1 mg |
| J3397 |
Injection, vestronidase alfa-vjbk, 1 mg |
| J3398 |
Injection, voretigene neparvovec-rzyl, 1 billion vector genomes |
| J3399 |
Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes |
| J3400 |
Injection, triflupromazine hcl, up to 20 mg |
| J3410 |
Injection, hydroxyzine hcl, up to 25 mg |
| J3411 |
Injection, thiamine hcl, 100 mg |
| J3415 |
Injection, pyridoxine hcl, 100 mg |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
| J3430 |
Injection, phytonadione (vitamin k), per 1 mg |
| J3465 |
Injection, voriconazole, 10 mg |
| J3470 |
Injection, hyaluronidase, up to 150 units |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
| J3472 |
Injection, hyaluronidase, ovine, preservative free, per 1000 usp units |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
| J3480 |
Injection, potassium chloride, per 2 meq |
| J3485 |
Injection, zidovudine, 10 mg |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
| J3489 |
Injection, zoledronic acid, 1 mg |
| J3490 |
Unclassified drugs |
| J3520 |
Edetate disodium, per 150 mg |
| J3530 |
Nasal vaccine inhalation |
| J3535 |
Drug administered through a metered dose inhaler |
| J3570 |
Laetrile, amygdalin, vitamin b17 |
| J3590 |
Unclassified biologics |
| J3591 |
Unclassified drug or biological used for esrd on dialysis |
| J7030 |
Infusion, normal saline solution , 1000 cc |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
| J7050 |
Infusion, normal saline solution, 250 cc |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
| J7070 |
Infusion, d5w, 1000 cc |
| J7100 |
Infusion, dextran 40, 500 ml |
| J7110 |
Infusion, dextran 75, 500 ml |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
| J7131 |
Hypertonic saline solution, 1 ml |
| J7169 |
Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg |
| J7170 |
Injection, emicizumab-kxwh, 0.5 mg |
| J7175 |
Injection, factor x, (human), 1 i.u. |
| J7177 |
Injection, human fibrinogen concentrate (fibryga), 1 mg |
| J7178 |
Injection, human fibrinogen concentrate, not otherwise specified, 1 mg |
| J7179 |
Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco |
| J7180 |
Injection, factor xiii (antihemophilic factor, human), 1 i.u. |
| J7181 |
Injection, factor xiii a-subunit, (recombinant), per iu |
| J7182 |
Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu |
| J7183 |
Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco |
| J7185 |
Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. |
| J7186 |
Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. |
| J7187 |
Injection, von willebrand factor complex (humate-p), per iu vwf:rco |
| J7188 |
Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. |
| J7189 |
Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram |
| J7190 |
Factor viii (antihemophilic factor, human) per i.u. |
| J7191 |
Factor viii (antihemophilic factor (porcine)), per i.u. |
| J7192 |
Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified |
| J7193 |
Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. |
| J7194 |
Factor ix, complex, per i.u. |
| J7195 |
Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified |
| J7196 |
Injection, antithrombin recombinant, 50 i.u. |
| J7197 |
Antithrombin iii (human), per i.u. |
| J7198 |
Anti-inhibitor, per i.u. |
| J7199 |
Hemophilia clotting factor, not otherwise classified |
| J7200 |
Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu |
| J7201 |
Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. |
| J7202 |
Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. |
| J7203 |
Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu |
| J7204 |
Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu |
| J7205 |
Injection, factor viii fc fusion protein (recombinant), per iu |
| J7207 |
Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. |
| J7208 |
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. |
| J7209 |
Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. |
| J7210 |
Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. |
| J7211 |
Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. |
| J7212 |
Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram |
| J7296 |
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
| J7300 |
Intrauterine copper contraceptive |
| J7301 |
Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg |
| J7302 |
Levonorgestrel-releasing intrauterine contraceptive system, 52 mg |
| J7303 |
Contraceptive supply, hormone containing vaginal ring, each |
| J7304 |
Contraceptive supply, hormone containing patch, each |
| J7306 |
Levonorgestrel (contraceptive) implant system, including implants and supplies |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
| J7308 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) |
| J7309 |
Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram |
| J7310 |
Ganciclovir, 4.5 mg, long-acting implant |
| J7311 |
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg |
| J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg |
| J7313 |
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg |
| J7314 |
Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg |
| J7315 |
Mitomycin, ophthalmic, 0.2 mg |
| J7316 |
Injection, ocriplasmin, 0.125 mg |
| J7318 |
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
| J7321 |
Hyaluronan or derivative, hyalgan or supartz, for intra-articular injection, per dose |
| J7322 |
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
| J7326 |
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose |
| J7327 |
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
| J7329 |
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg |
| J7330 |
Autologous cultured chondrocytes, implant |
| J7331 |
Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg |
| J7332 |
Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg |
| J7333 |
Hyaluronan or derivative, visco-3, for intra-articular injection, per dose |
| J7335 |
Capsaicin 8% patch, per 10 square centimeters |
| J7336 |
Capsaicin 8% patch, per square centimeter |
| J7340 |
Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml |
| J7342 |
Instillation, ciprofloxacin otic suspension, 6 mg |
| J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg |
| J7351 |
Injection, bimatoprost, intracameral implant, 1 microgram |
| J7352 |
Afamelanotide implant, 1 mg |
| J7401 |
Mometasone furoate sinus implant, 10 micrograms |
| J7500 |
Azathioprine, oral, 50 mg |
| J7501 |
Azathioprine, parenteral, 100 mg |
| J7502 |
Cyclosporine, oral, 100 mg |
| J7503 |
Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg |
| J7504 |
Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg |
| J7505 |
Muromonab-cd3, parenteral, 5 mg |
| J7506 |
Prednisone, oral, per 5 mg |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
| J7508 |
Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg |
| J7509 |
Methylprednisolone oral, per 4 mg |
| J7510 |
Prednisolone oral, per 5 mg |
| J7511 |
Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
| J7513 |
Daclizumab, parenteral, 25 mg |
| J7515 |
Cyclosporine, oral, 25 mg |
| J7516 |
Cyclosporin, parenteral, 250 mg |
| J7517 |
Mycophenolate mofetil, oral, 250 mg |
| J7518 |
Mycophenolic acid, oral, 180 mg |
| J7520 |
Sirolimus, oral, 1 mg |
| J7525 |
Tacrolimus, parenteral, 5 mg |
| J7527 |
Everolimus, oral, 0.25 mg |
| J7599 |
Immunosuppressive drug, not otherwise classified |
| J7604 |
Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram |
| J7605 |
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
| J7606 |
Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
| J7607 |
Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg |
| J7608 |
Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
| J7612 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
| J7615 |
Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
| J7622 |
Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7624 |
Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
| J7627 |
Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg |
| J7628 |
Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7629 |
Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7631 |
Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
| J7632 |
Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
| J7633 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
| J7634 |
Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram |
| J7635 |
Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7636 |
Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7637 |
Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7638 |
Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7639 |
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7640 |
Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms |
| J7641 |
Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram |
| J7642 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7643 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7645 |
Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7647 |
Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7648 |
Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
| J7649 |
Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7650 |
Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7657 |
Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7658 |
Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
| J7659 |
Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7660 |
Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7665 |
Mannitol, administered through an inhaler, 5 mg |
| J7667 |
Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams |
| J7668 |
Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams |
| J7669 |
Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
| J7670 |
Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
| J7674 |
Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
| J7676 |
Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg |
| J7677 |
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
| J7680 |
Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7681 |
Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7682 |
Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams |
| J7683 |
Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7684 |
Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7685 |
Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams |
| J7686 |
Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg |
| J7699 |
Noc drugs, inhalation solution administered through dme |
| J7799 |
Noc drugs, other than inhalation drugs, administered through dme |
| J7999 |
Compounded drug, not otherwise classified |
| J8498 |
Antiemetic drug, rectal/suppository, not otherwise specified |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
| J8501 |
Aprepitant, oral, 5 mg |
| J8510 |
Busulfan; oral, 2 mg |
| J8515 |
Cabergoline, oral, 0.25 mg |
| J8520 |
Capecitabine, oral, 150 mg |
| J8521 |
Capecitabine, oral, 500 mg |
| J8530 |
Cyclophosphamide; oral, 25 mg |
| J8540 |
Dexamethasone, oral, 0.25 mg |
| J8560 |
Etoposide; oral, 50 mg |
| J8562 |
Fludarabine phosphate, oral, 10 mg |
| J8565 |
Gefitinib, oral, 250 mg |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
| J8600 |
Melphalan; oral, 2 mg |
| J8610 |
Methotrexate; oral, 2.5 mg |
| J8650 |
Nabilone, oral, 1 mg |
| J8655 |
Netupitant 300 mg and palonosetron 0.5 mg, oral |
| J8670 |
Rolapitant, oral, 1 mg |
| J8700 |
Temozolomide, oral, 5 mg |
| J8705 |
Topotecan, oral, 0.25 mg |
| J8999 |
Prescription drug, oral, chemotherapeutic, nos |